# SAPHNELO
> **BLA761123** · Biologics License Application · Sponsor: ASTRAZENECA AB · Approved 2021-07-30
## Drug
- **FDA Application Number:** BLA761123
- **Application type:** Biologics License Application
- **Brand name:** SAPHNELO
- **Generic name:** ANIFROLUMAB-FNIA
- **Active ingredients:** ANIFROLUMAB-FNIA
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ASTRAZENECA AB
- **Manufacturer:** AstraZeneca Pharmaceuticals LP
- **First approval:** 2021-07-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761123)
---
*AI Analytics · CC0 1.0*